VENTRICULAR REMODELING IN HEART FAILURE

心力衰竭时的心室重构

基本信息

  • 批准号:
    6683623
  • 负责人:
  • 金额:
    $ 9.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-05-01 至 2004-04-30
  • 项目状态:
    已结题

项目摘要

The applicant has established a record of success in patient- oriented research and training of clinical investigators. However, only 10 percent of his time is protected for patient-oriented clinical research because of extensive and demanding clinical duties. If awarded, this grant will allow the applicant to devote 50 percent of his time performing funded clinical CHF studies and initiated novel projects. More importantly, this award will enable the applicant to more narrowly focus his funded patient-oriented research program in the area of left ventricular (LV) remodeling in congestive heart failure (CHF) and to acquire new skills need to translate new developments in molecular biology into clinical research. Currently, the applicant is co-principal investigator and Director of the Echocardiography Core Lab for the BEST (Beta-Blocker Evaluation of Survival Trial) Study sponsored by the NHLBI/VA Cooperative Studies Program. The specific aims of this BEST Echocardiography Substudy are to 1) determine which echocardiographic variables are independent predictors of survival and hemodynamic improvement in CHF, 2) assess whether beta-blocker therapy improves LV remodeling, and 3) evaluate whether contractile reserve predicts a favorable response of LV remodeling to beta-blocker therapy. This award, if grant, will allow completion of this project within two years. In addition, the investigator is developing a new method of quantitative assessment of myocardial blood flow reserve ratio by contrast echocardiography using new perfluorocarbon-filled microspheres. This method has been validated in dogs and its validation in humans has recently been funded. The long term goals of the investigator are to use this method to 1) assess the role of microvascular function in the development of clinical CHF and LV remodeling, and 2) evaluate the effect of specific CHF therapies on microvascular function. This work is planned for the later years of this grant proposal after initial validation studies have been completed. Finally, if awarded this grant will allow the investigator to conduct translational research involving the molecular signals for LV remodeling in chronic mitral regurgitation. The long range goals of this project are to identify patients in whom LV failure is imminent for early surgical intervention and to develop therapeutic targets for eccentric LV remodeling in chronic mitral regurgitation and dilated cardiomyopathies.
申请人在以患者为导向的研究和临床研究者培训方面取得了成功。然而,由于广泛而苛刻的临床职责,他只有10%的时间用于以患者为导向的临床研究。 如果获奖,该补助金将允许申请人投入50%的时间进行资助的临床CHF研究和启动新项目。 更重要的是,该奖项将使申请人能够更专注于充血性心力衰竭(CHF)左心室(LV)重塑领域的以患者为导向的研究计划,并获得将分子生物学的新发展转化为临床研究所需的新技能。目前,申请人是由NHLBI/VA合作研究项目申办的BEST(β受体阻滞剂生存试验评价)研究的共同主要研究者和超声心动图核心实验室主任。 这项BEST超声心动图子研究的具体目的是:1)确定哪些超声心动图变量是CHF患者生存率和血流动力学改善的独立预测因素,2)评估β受体阻滞剂治疗是否改善LV重塑,3)评价收缩储备是否预测LV重塑对β受体阻滞剂治疗的有利反应。 该奖项,如果赠款,将允许在两年内完成这个项目。 此外,研究者正在开发一种新的方法,通过使用新的全氟化碳填充微球的超声造影定量评估心肌血流储备率。这种方法已经在狗身上得到了验证,最近也得到了资助。 研究者的长期目标是使用该方法1)评估微血管功能在临床CHF和LV重塑发展中的作用,2)评价特定CHF治疗对微血管功能的影响。 这项工作计划在最初的验证研究完成后,在本赠款提案的后期进行。 最后,如果获得该资助,研究者将能够进行涉及慢性二尖瓣返流中LV重构分子信号的转化研究。 本项目的长期目标是识别LV衰竭即将进行早期手术干预的患者,并开发慢性二尖瓣返流和扩张型心肌病中偏心性LV重塑的治疗靶点。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.
有二尖瓣反流的心力衰竭患者与无二尖瓣反流的患者 B 型利尿钠肽水平的比较。
  • DOI:
    10.1016/j.amjcard.2004.01.008
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mayer,SusanA;DeLemos,JamesA;Murphy,SabinaA;Brooks,Sandra;Roberts,BradJ;Grayburn,PaulA
  • 通讯作者:
    Grayburn,PaulA
Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress: comparison with (99m)Tc-sestamibi SPECT imaging.
通过谐波功率多普勒成像评估静息和腺苷应激期间的心肌灌注:与 (99m)Tc-sestamibi SPECT 成像进行比较。
  • DOI:
    10.1161/01.cir.102.1.55
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Heinle,SK;Noblin,J;Goree-Best,P;Mello,A;Ravad,G;Mull,S;Mammen,P;Grayburn,PA
  • 通讯作者:
    Grayburn,PA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul A Grayburn其他文献

881-4 Delivery of Luciferase enzyme to the heart using ultrasound targeted microbubble destruction
  • DOI:
    10.1016/s0735-1097(04)91583-5
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Raffi Bekeredjian;Shuyuan Chen;Paul A Grayburn;Ralph V Shohet
  • 通讯作者:
    Ralph V Shohet

Paul A Grayburn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul A Grayburn', 18)}}的其他基金

GENE THERAPY TO REVERSE DIABETES
逆转糖尿病的基因疗法
  • 批准号:
    8357703
  • 财政年份:
    2011
  • 资助金额:
    $ 9.12万
  • 项目类别:
ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION TO DELIVER GD MRI CONTRAST AGENTS
超声定向微泡破坏以提供 GD MRI 造影剂
  • 批准号:
    7180724
  • 财政年份:
    2005
  • 资助金额:
    $ 9.12万
  • 项目类别:
ULTRASOUND TECHNIQUE TO DELIVER GD MRI CONTRAST AGENTS
提供 GD MRI 造影剂的超声技术
  • 批准号:
    6977493
  • 财政年份:
    2004
  • 资助金额:
    $ 9.12万
  • 项目类别:
Functional MR in Ischemic Cardiomyopathy
功能性磁共振在缺血性心肌病中的应用
  • 批准号:
    6574205
  • 财政年份:
    2002
  • 资助金额:
    $ 9.12万
  • 项目类别:
Functional MR in Ischemic Cardiomyopathy
功能性磁共振在缺血性心肌病中的应用
  • 批准号:
    7497238
  • 财政年份:
    2002
  • 资助金额:
    $ 9.12万
  • 项目类别:
Functional MR in Ischemic Cardiomyopathy
功能性磁共振在缺血性心肌病中的应用
  • 批准号:
    6771737
  • 财政年份:
    2002
  • 资助金额:
    $ 9.12万
  • 项目类别:
Functional MR in Ischemic Cardiomyopathy
功能性磁共振在缺血性心肌病中的应用
  • 批准号:
    6666767
  • 财政年份:
    2002
  • 资助金额:
    $ 9.12万
  • 项目类别:
Functional MR in Ischemic Cardiomyopathy
功能性磁共振在缺血性心肌病中的应用
  • 批准号:
    6930425
  • 财政年份:
    2002
  • 资助金额:
    $ 9.12万
  • 项目类别:
VENTRICULAR REMODELING IN HEART FAILURE
心力衰竭时的心室重构
  • 批准号:
    6638083
  • 财政年份:
    1999
  • 资助金额:
    $ 9.12万
  • 项目类别:
VENTRICULAR REMODELING IN HEART FAILURE
心力衰竭时的心室重构
  • 批准号:
    2835621
  • 财政年份:
    1999
  • 资助金额:
    $ 9.12万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.12万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 9.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了